Treatment of COVID-19 with convalescent plasma in patients with humoral immunodeficiency – Three consecutive cases and review of the literature

Patients lacking humoral response have been suggested to develop a less severe COVID-19, but there are some reports with a prolonged, relapsing or deadly course. From April 2020, there is growing evidence on the benefits of COVID-19 convalescent plasma (CCP) for patients with humoral immunodeficienc...

詳細記述

保存先:
書誌詳細
出版年:Enferm Infecc Microbiol Clin
主要な著者: Delgado-Fernández, Marcial, García-Gemar, Gracia Mar, Fuentes-López, Ana, Muñoz-Pérez, Manuel Isidro, Oyonarte-Gómez, Salvador, Ruíz-García, Ignacio, Martín-Carmona, Jessica, Sanz-Cánovas, Jaime, Castaño-Carracedo, Manuel Ángel, Reguera-Iglesias, José María, Ruíz-Mesa, Juan Diego
フォーマット: Artigo
言語:Inglês
出版事項: Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. 2022
主題:
Review Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7877207/
https://ncbi.nlm.nih.gov/pubmed/33741148
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eimc.2021.01.013
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料